Trial intelligence / Profile preview

PENG Block vs Morphine for Proximal Femur Fracture

NCT05023473Completed

Sponsor
Suez Canal University
Start
Apr 2022
Primary completion
Aug 2022
Countries
1
01

Overview

Randomised, open-label trial (2 arms), sponsored by Suez Canal University. Primary endpoint: Morphine consumption at 24 hours. Started Apr 2022; status: completed.

Beyond the preview

Go deeper on NCT05023473.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05023473.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call